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.Summary Background: A number of reports from developed countries have
documented a rising age at which pleural tuberculosis occurs and increase in the
frequency of reactivation disease being as the main cause of pleural involvement.
Objective: To determine the age at which pleural tuberculosis occurs, study its
clinical pattern, and to determine whether pleural tuberculosis is a result of
reactivation of pulmonary tuberculosis or it is a primary one comparing our findings
with results from developed countries.
Method: Retrospective study of 100 cases discharged from Hamad General
Hospital with the diagnosis of pleural tuberculosis from January 1996 to December
2002.
Results: Pleural tuberculosis tends to affect younger age groups (84% are below
the age of 45 years, with mean age of 31.5). The disease tends to be mostly a
primary infection. Fever is the most common symptom (90%) and the disease is
usually an acute or sub acute one. Weight loss precedes other symptoms. Exudative
pleural effusion with predominant lymphocytosis is characteristic. Majority of
patients have no predisposing conditions for the disease.
Conclusion: In contrast to what has been reported in some developed countries,
Pleural tuberculosis tends to be a primary disease in the present study. Younger age
groups are particularly affected.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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.qa, abaribener@hotmail.Introduction
Tuberculosis still a leading cause of death world-
wide, especially in sub-Saharan Africa whereed.
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Table 1 Socio-demographic, past history and
disease detail of the patients.
N ¼ 100 n(%)
Gender
Male 94(94.0)
Female 6(6.0)
Nationality
Qatari 4(4.0)
Non-Qatari 96(96.0)
Age group
o35 years 56(56.0)
35–45 years 29(29.0)
445 years 15(15.0)
Past history of TB
Yes 1(1.0)
No 99(99.0)
History of contact with TB patient
Yes 9(9.0)
No 91(91.0)
Diabetes mellitus
Yes 5(5.0)
No 95(95.0)
HIV
Yes 1(1.0)
No 99(99.0)
Asthma
Yes 0(0.0)
No 100(100.0)
COPD
Yes 0(0.0)
No 100(0.0)
Use of immunosuppressant drug
Yes 9(9.0)
No 91(91.0)
Smoking habits
Smoker 26(26.0)
Non-smoker 74(74.0)
Does pleural tuberculosis disease pattern differ among developed and developing countries 1039infection with HIV virus has caused a large excess in
incidence and mortality from active tuberculosis.1
Pleural involvement remains the most common
extra pulmonary manifestation of tuberculous
infection.2,3 Pleural tuberculosis is still considered
in developed countries as a disease of older
population.4 Pleural tuberculosis is usually an acute
febrile illness, it is thought to result from a delayed
hypersensitivity reaction to mycobacterial antigen
in the pleural space, these antigens may enter from
a parenchymal lung focus.
Since the introduction of anti-tuberculous che-
motherapy and control measures there has been a
marked reduction in the incidence of tuberculosis
in the developed world. This has lead to the result
that pleural tuberculosis being more commonly due
to reactivation than primary infection in developed
countries and complicates about 7% of cases of
active pulmonary tuberculosis.5
A study from Edinburgh2,6 for the years
1980–1991 noting reactivation as a cause of
tuberculous effusions in 40.3% while in 22.5% of
cases the effusion was primary. Another study from
Los Angeles7 showed that 46% of cases of pleural
tuberculosis were due to reactivation disease.
Pleural tuberculosis is still a difficult disease to
diagnose; Pleural biopsy remains the gold standard
for the diagnosis of pleural tuberculosis.2,8
The peninsula of Qatar lies half way along the
west coast of the Arabian Gulf. The population of
Qatar is around 769,152 (July 2001 estimate), 80%
are foreign workers, majority of these expatriates
are Asians (Indians, Bangladeshi, Nepali, and
Arabs). Africans, Europeans and Americans consti-
tute a minor proportion. Hamad Medical Corpora-
tion is the main health care provider in the state of
Qatar with Hamad General hospital and Rumailah
hospital being the main teaching hospitals.
The objective of the present study was to
determine the age at which pleural tuberculosis
occurs in HIV negative and HIV positive patients,
study the demographic, clinical pattern and risk
factors of pleural tuberculosis, and to determine
whether pleural tuberculosis is a result of reactiva-
tion of pulmonary disease or it is a primary disease,
comparing the situation in developed and develop-
ing countries.Methods
A retrospective study of cases admitted to Hamad
General hospital during the period from 1996 to
2002 and diagnosed with certainty as pleural TB
was conducted.Inclusion criteria
The diagnosis should be based on: Presence of
pleural effusion in a patient with one of the
following criteria:1. Histological findings of caseating granuloma.
2. Histological findings of non-caseating granuloma
with clinical picture consistent with pleural
tuberculosis &/or positive sputum for AFB &/or
Positive PPD.
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Table 2 Frequency of Symptoms and duration of symptoms among patients by age group.
N ¼ 104nð%Þ Duration of symptoms in days
o35 years X35 years
Median Mean7SD 95% CI Median Mean7SD 95% CI
Fever 93(89.4) 15.00 29.39735.8 18.75–40.03 12.00 20.49731.8 9.57–31.40
Cough 90(86.5) 21.00 38.86750.7 24.31–53.41 14.00 25.58735.7 12.50–38.66
Sputum 42(40.4) 14.0 25.84726.3 13.17–38.51 13.00 29.31745.6 5.00–53.63
Hemoptysis 5(4.8) 22.00 27.25724.2 11.19–65.69 — — —
Weight loss 59(56.7) 60.0 71.00753.4 48.95–93.05 30.00 68.93768.5 29.37–108.49
Shortness of breathy 33(31.7) 15.00 27.07730.0 10.45–43.68 8.00 10.5477.4 6.07–15.00
Pleuratic pain 61(58.7) 15.00 31.46738.0 16.12–46.81 14.00 36.96751.1 15.86–58.06
Night sweating 60(57.7) 21.00 35.22735.1 21.32–49.13 10.00 25.90741.6 6.42–45.38
Mann–Whitney test was used to compare duration of symptoms among the two age groups.
yP ¼ 0:044:
W.H. Ibrahim et al.10403. Positive pleural fluid, &/or pleural biopsy for
AFB.
Criteria for diagnosing reactivation pleural
tuberculosis
We depend on the same criteria used by authors
from developed countries4,6,10,11 to diagnose pleur-
al tuberculosis secondary to reactivation which are:1. Absence of any parenchymal lung disease.
2. Absence of past history of pulmonary tubercu-
losis.A total of 104 cases were found to be discharged
with the diagnosis of pleural tuberculosis during the
period from January 1996 to December 2002. Out of
this number 4 cases were excluded from the study
as they did not fulfill our criteria of diagnosis
mentioned above. The remaining 100 cases were
included as they fulfill the criteria. Various points in
the history, clinical examination, radiological,
laboratory, Microbiological, Histopathological were
investigated and recorded in a sheet. Adenosine
deaminase of the pleural fluid was not done in any
of the cases because it was not available in Hamad
general hospital during that period.
Various data were obtained from the medical
records of the patients including hospital number,
age, sex, past history of tuberculosis, history of
diabetes, HIV infection, COPD, asthma, history of
contact with tuberculosis case, drug history like
immunosuppressants, steroids, antituberculous
drugs, smoking history, different symptoms and
duration for each, radiological findings, biochem-ical parameters in the blood, PPD readings, result
of sputum direct smear and culture for AFB,
characteristics of pleural fluid and the result of
fluid direct smear and culture for AFB, the
histopathological and microbiological result of
pleural biopsy, whether the biopsy was complicated
by pneumothorax, and the various drug sensitivities
of the AFB.
Data analysis
The Statistical Package for Social Sciences9 (SPSS)
was used for statistical analysis. Data are expressed
as mean and standard deviation (SD) unless other-
wise stated. Student’s t test was used to ascertain
the significance of differences between mean
values of two continuous variables and the Man-
n–Whitney test performed for nonparametric test.
w2 analysis was performed to test for differences in
proportions of categorical variables between two or
more groups. The cut-off value for significance was
considered to be Po0:05:Results
Table 1 shows the demographic features of pleural
tuberculosis. As can be seen from the table, Pleural
tuberculosis tends to affect younger age groups
(85.0% are below the age of 46 years). The mean
age of the study subjects was 31.777.1. This is
different from what was thought to be in the past.4
Only one patient in our study is HIV positive (his age
at presentation was 66 years). The presence of
complications like diabetes, asthma, COPD and use
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Table 3 Laboratory findings among the patients.
Age o35, N ¼ 56 n(%) AgeX35, N ¼ 44 n(%) Total
CXR findings
Right effusion 33(58.9) 25(56.8) 58(58.0)
Left effusion 27(48.2) 20(45.5) 47(47.0)
Bilateral pleural effusion 4(7.1) 1(2.3) 5(5.0)
Consolidation 9(16.1) 5(11.4) 14(14.0)
Fibrosis 1(1.8) 5(11.4) 6(6.0)
Cavitation 0(0.0) 4(9.1) 4(4.0)
Haemoglobin (g/dl)
p12 18(32.1) 12(27.3) 30(30.0)
412 38(67.9) 32(72.7) 70(70.0)
WBC (10^9/l)
4–10 52(92.9) 38(86.4) 90(90.0)
410 4(7.1) 6(13.6) 10(10.0)
Neutrophils (%)
45–74% 38(67.9) 30(68.2) 68(68.0)
474% 18(32.1) 14(31.8) 32(32.0)
Lymphocytes (%)
o16% 25(44.6) 21(47.7) 46(46.0)
16–45% 31(55.4) 23(52.3) 54(54.0)
ESR (mm/h)
o20 5(8.9) 3(6.8) 8(8.0)
20–40 14(25.0) 10(22.7) 24(24.0)
440 37(66.1) 31(70.5) 68(68.0)
PPD mm (mean7SD) 20.0675.5 17.3374.6 0.042
Platelets (10^9/l)
150–400 32(57.1) 23(52.3) 55(55.0)
401–500 17(30.4) 13(29.5) 30(30.0)
4500 7(12.5) 8(18.2) 15(15.0)
Serum albumin(g/l)
25–35 37(66.1) 29(65.9) 66(66.0)
36–55 19(33.9) 15(34.1) 34(34.0)
Sputum for AFB (direct smear)
Positive 2(3.6) 4(9.1) 6(6.0)
Negative 54(96.4) 40(90.9) 94(94.0)
Sputum for AFB (culture)
Positive 10(17.9) 13(29.5) 23(23.0)
Negative 46(82.1) 31(70.5) 77(77.0)
P ¼ 0:042:
Does pleural tuberculosis disease pattern differ among developed and developing countries 1041of immunosuppressant drug was uncommon among
the study subjects. (5.0%, 0%, 0%, 9%, respec-
tively). In total, 26.0% of the subjects were
smokers.
Table 2 shows the symptoms in order of
frequency and their durations. Fever is the most
common presenting symptom (90.0%) followed by
cough (86.0%), Pleuratic pain (60%) and night
sweats (57.0%). The disease tends to be an acute
illness rather than a chronic one as the duration ofsymptoms are less than 30 days at presentation (in
71.4–83.9% of cases) except for weight loss,
indicting that weight loss is the earliest symptom
to occur. The duration of symptoms showed a high
deviation and interestingly duration of shortness of
breath was significantly higher the younger group
(ageo35 years), P ¼ 0:044:
Table 3 shows the chest X-ray and laboratory
findings. The disease is mostly a primary infection
rather than a reactivation of co-existing pulmonary
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Table 4 Pleural fluid analysis by age group.
Age o35, N ¼ 56 n(%) AgeX35, N ¼ 44 n(%) Total
Fluid color
Straw 52(92.9) 38(86.4) 90(90.0)
Hemorrhagic 4(7.1) 5(11.3) 9(9.0)
Purulent 0(0.0) 1(2.3) 1(1.0)
Pleural pH
p7.2 4(7.1) 1(2.3) 5(5.0)
47.2 52(92.9) 43(97.7) 95(95.0)
Protein g/l
o30 0(0.0) 1(2.3) 1(1.0)
X30 56(100.0) 43(97.7) 99(99.0)
Fluid protein/serum protein ratio
o0.5 1(1.8) 0(0.0) 1(1.0)
40.5 55(98.2) 44(100.0) 99(99.0)
Fluid glucose (mmol/l)
o3.5 28(50.0) 9(20.5) 37(35.6)
43.5 28(50.0) 35(79.5) 63(63.0)
Fluid LDH level u/l
o350 2(3.6) 1(2.3) 3(3.0)
4350 54(96.4) 43(97.7) 97(97.0)
The predominant cells
Predominant lymphocytes 54(96.4) 39(88.6) 93(93.0)
Predominant neutrophil 2(3.6) 5(11.4) 7(7.0)
Fluid AFB (culture)
Positive 10(17.9) 13(29.5) 23(23.0)
Negative 46(82.1) 31(70.5) 77(77.0)
Caseating granuloma
Yes 41(73.2) 32(72.7) 73(73.0)
No 15(26.8) 12(27.3) 27(27.0)
Non-caseating granuloma
Yes 12(21.4) 10(22.7) 22(22.0)
No 44(78.6) 34(77.3) 78(78.0)
Pleural biopsy of AFB direct smear
Yes 5(8.9) 4(9.1) 9(9.0)
No 51(91.1) 40(90.9) 91(91.0)
Pleural biopsy of AFB culture sensitivity
Yes 29(51.8) 25(56.8) 54(54.0)
No 27(48.2) 19(43.2) 46(46.0)
Pneumothorax as complication
Yes 8(14.3) 5(11.4) 13(13.0)
No 48(85.7) 39(88.6) 87(87.0)
P ¼ 0:002:
W.H. Ibrahim et al.1042tuberculosis (Past history of tuberculosis is absent
in 99% of cases, evidence of parenchymal lung
lesions are absent in 78% of cases). Right pleural
effusion is slightly more common than left (58%
compared to 47%). Up to 5% of cases may havebilateral pleural effusion. In total, 30.0% of
patients are Anemic at presentation. ESR is
elevated in majority of cases (above 40mm/h in
68%). PPD was significantly higher among younger
age group (o35 years) (20.0675.5 vs. 17.3374.6,
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Does pleural tuberculosis disease pattern differ among developed and developing countries 1043P ¼ 0:042). Pleural biopsies were performed among
83(83.0%) of the cases.
Table 4 shows pleural fluid analysis results.
Almost all patients have exudative effusion with
fluid protein more than 30 g/l and LDH level more
than 350 mm/l 99.0%.
Sputum culture gives a better positive yield than
direct smear examination (23.0% compared to
6.0%). While pleural fluid direct smear is negative
in all cases, pleural fluid culture for mycobacteria
is positive in 23.0%. Predominant lymphocytes were
higher among the younger subjects (o35 years)
96.4% vs. 88.6%).
Looking at drug sensitivity of mycobacteria
towards anti-TB drugs INH resistance is seen in
6.3% of cases, while Rifampicin resistance is seen in
2.1% of cases.
Fig. 1 shows the histogram of PPD readings and
Table 5 shows the trend of active and pleural TB5.00 10.00 15.00 20.00 25.00 30.00
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Figure 1 The histogram of PPD readings ðN ¼ 100Þ:
Table 5 Incidence of active and pleural TB cases in Qat
Year Population Active TB
1996 510070 257
1997 526427 212
1998 543315 253
1999 560746 258
2000 578470 279
2001 595321 281
2002 616138 278cases during the years 1996–2002. Also, in Table 5,
the percentage of pleural TB from active TB is
shown.
The diagnosis of pleural tuberculosis is based on
clinical findings, chest radiography, PPD testing,
and pleural fluid analysis. Pleural biopsy remains
the gold-standard for the diagnosis (Table 6).
Pleural biopsy was done in our study on the
83(83.0%) cases.Discussion
Reports from some developed countries documen-
ted that pleural tuberculosis is more frequent in
older age group suggesting that it may be due to
reactivation disease.4,6,10,11 However, the situation
in developing countries is not clear. In our study, we
found that the disease is mainly a primary one
rather than a reactivation of previous parenchymal
lung tuberculosis.
Table 7 shows examples of the situation in some
developed and developing countries. In addition we
found that pleural tuberculosis tends to affect
younger age groups (84% are below the age of 45
years and 56% are below the age of 35 years).
These findings may be explained partly by the
reduction in incidence of tuberculosis in developed
world.2 Therefore, with fewer new infections,
pleural disease now more commonly accompanies
reactivation than primary infection in developed
countries.
The mean age in our study was 34.8 years;
however, most of the foreigners in the Gulf area are
in the working age group, therefore this can be
misleading.
The unilateral tuberculous effusion reported in
our study confirmed previous findings of right-sided
predominance.6,12
One recent study from Spain 13 describing pleural
tuberculosis in children showed that history of
contact with a tuberculous case was positive inar.
Pleural TB Pleural TB (%) from
active TB (%)
5 1.9
22 10.4
10 4.0
14 5.4
31 11.1
5 1.8
13 4.7
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Table 6 Diagnostic yield for pleural tuberculosis.
Series No. of cases Fluid culture
positive (%)
Biopsy histology
positive (%)
Biopsy culture
positive (%)
Sibley (1950) 74 28 NS NS
Roper (1955) 99 51 NS NS
Scharer(1968) 40 23 63 55
Levine(1970) 21 48 71 76
Berger(1973) 49 24 69y 65
Epstein(1987) 23 35 56y 39
Antoniskis(1990) 59 77 58y 52
Maartens(1991) 62 47 84y 71
Chan(1991) 83 23 51 40
Seibert(1991) 70 58 84y 67
Moudgil(1994) 62 54 60 NS
Batungwanayo(1993) 90 46 52y 50
Relkin(1994) 70 86 80y 66
Kirsch(1997) 30 NS 80y 60
Ibrahim et al. (2004) 100 25.3 83 54.2
NS ¼ not specified.
Richard S Morehead; Tuberculosis of the pleura; Southern Medical Journal;1998; 91; 630–637.
Caseating granuloma
yCaseating or non-caseating granulomas &/or positive AFB Smear.
Table 7 Percentage of Primary and Reactivation Pleural TB.
Author Year Primary (%) Reactivation (%) Country
Antoniskis et al.7 1990 54 46 USA
Moudgil et al.6 1994 22.5 40.3 UK
Arriero et al.14 1998 76 24 Spain
Liam et al.15 1999 63.7 36.3 Malaysia
Ibrahim et al. (Present study) 2004 78 22 Qatar
W.H. Ibrahim et al.104425.7% of patients, however, in our study we found
only 9.0% of our patients had such history, indicat-
ing that contact with tuberculous cases seems to be
less evident in adults.
Sputum direct microscopy for AFB seems to be of
no use in diagnosing primary pleural tuberculosis.Conclusion
We conclude that, in contrast to what has been
reported in some developed countries, pleural
tuberculosis tends to be a primary disease rather
than a reactivation of parenchymal disease, young-
er age groups are particularly affected. We suggest
that further prospective studies are needed to
confirm these findings and to find an explanation
for the differences particularly in regard to social
and nutritional status and pathogenesis of disease.References
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